SWM
PFE icon

Sculati Wealth Management’s Pfizer PFE Stock Holding History

Sculati Wealth Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-10,376
Closed -$291K – 125
2026
Q1 		$291K Sell
10,376
-512
-5% -$13.6K 0.11% 107
2025
Q4 		$271K Sell
10,888
-2,746
-20% -$69.2K 0.1% 108
2025
Q3 		$347K Sell
13,634
-1,456
-10% -$35.9K 0.12% 96
2025
Q2 		$366K Sell
15,090
-5,989
-28% -$140K 0.14% 97
2025
Q1 		$534K Sell
21,079
-3,598
-15% -$94.2K 0.22% 72
2024
Q4 		$655K Sell
24,677
-5,305
-18% -$144K 0.26% 68
2024
Q3 		$868K Sell
29,982
-22,409
-43% -$654K 0.35% 66
2024
Q2 		$1.47M Sell
52,391
-1,596
-3% -$43.9K 0.63% 51
2024
Q1 		$1.5M Sell
53,987
-2,329
-4% -$64.6K 0.65% 52
2023
Q4 		$1.62M Sell
56,316
-6,045
-10% -$183K 0.76% 46
2023
Q3 		$2.07M Buy
62,361
+2,325
+4% +$82.2K 1.06% 29
2023
Q2 		$2.2M Buy
60,036
+548
+0.9% +$21.3K 1.11% 27
2023
Q1 		$2.43M Buy
59,488
+2,000
+3% +$86.4K 1.29% 24
2022
Q4 		$2.95M Buy
57,488
+77
+0.1% +$3.69K 1.66% 14
2022
Q3 		$2.51M Buy
57,411
+2,115
+4% +$103K 1.48% 16
2022
Q2 		$2.9M Buy
55,296
+1,984
+4% +$101K 1.65% 12
2022
Q1 		$2.76M Buy
53,312
+1,458
+3% +$75.6K 1.35% 17
2021
Q4 		$3.06M Buy
51,854
+114
+0.2% +$5.65K 1.48% 18
2021
Q3 		$2.23M Buy
51,740
+2,540
+5% +$113K 1.18% 27
2021
Q2 		$1.93M Buy
49,200
+425
+0.9% +$16.5K 1.02% 32
2021
Q1 		$1.77M Buy
48,775
+3,048
+7% +$108K 1.02% 35
2020
Q4 		$1.68M Sell
45,727
-1,536
-3% -$56.3K 1.11% 30
2020
Q3 		$1.65M Buy
47,263
+1,789
+4% +$62.7K 1.23% 28
2020
Q2 		$1.41M Buy
45,474
+4,014
+10% +$136K 1.19% 30
2020
Q1 		$1.28M Buy
41,460
+4,662
+13% +$159K 1.41% 24
2019
Q4 		$1.37M Buy
+36,798
New +$1.31M 1.23% 31

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sculati Wealth Management's PFE Position: Q2 2026 in Review

Sculati Wealth Management sold out of Pfizer (PFE) in Q2 2026, closing a stake of 10,376 shares — an estimated $291K sold.

Sculati Wealth Management first reported a position in PFE in Q4 2019 and held it in 26 quarters. The position peaked at $3.06M in Q4 2021. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sculati Wealth Management reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Sculati Wealth Management sold 10,376 Pfizer shares in Q2 2026, an estimated $291K.
  • Sculati Wealth Management first reported a position in Pfizer in Q4 2019 and held it in 26 quarters.
  • Sculati Wealth Management's Pfizer position peaked at $3.06M in Q4 2021.
  • 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sculati Wealth Management's 13F filing for Q2 2026, filed 21 Jul 2026.